CAS 1464150-99-9

Benzonitrile, 4-[6-[4-(4-morpholinylcarbonyl)phenyl]imidazo[1,2-b]pyridazin-3-yl]-

Description:

Benzonitrile, 4-[6-[4-(4-morpholinylcarbonyl)phenyl]imidazo[1,2-b]pyridazin-3-yl]- is a complex organic compound characterized by its unique structural features, which include a benzonitrile moiety and an imidazopyridazine framework. This compound typically exhibits properties associated with both aromatic and heterocyclic compounds, such as stability and potential for various chemical reactions. The presence of the morpholine group suggests it may have solubility in polar solvents and could participate in hydrogen bonding. Additionally, the nitrile functional group contributes to its reactivity, particularly in nucleophilic addition reactions. The compound's molecular structure indicates potential applications in medicinal chemistry, possibly as a pharmaceutical agent, due to the presence of multiple functional groups that can interact with biological targets. Its specific characteristics, including melting point, boiling point, and spectral properties, would require empirical data for precise determination, but it is likely to exhibit typical behavior of similar organic compounds in terms of reactivity and solubility.

Formula: C₂₄H₁₉N₅O₂

Synonyms:

• ETC-168
• Benzonitrile, 4-[6-[4-(4-morpholinylcarbonyl)phenyl]imidazo[1,2-b]pyridazin-3-yl]-

ETC-168

CAS: 1464150-99-9

ETC-168 is a selective, orally active MNK inhibitor with IC50 values of 23 nM for MNK1 and 43 nM for MNK2. It demonstrates antiproliferative efficacy both in vivo and in vitro [1].

Formula: C₂₄H₁₉N₅O₂

Color and Shape: Solid

Molecular weight: 409.44

Ref: TM-T86385